Camelot Portfolios, LLC Novo Nordisk A S Transaction History
Camelot Portfolios, LLC
- $179 Million
- Q2 2024
A detailed history of Camelot Portfolios, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Camelot Portfolios, LLC holds 10,439 shares of NVO stock, worth $1.17 Million. This represents 0.83% of its overall portfolio holdings.
Number of Shares
10,439Holding current value
$1.17 Million% of portfolio
0.83%Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,961Shares Held
320MCall Options Held
5.16MPut Options Held
4.96M-
Jennison Associates LLC21.2MShares$2.38 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.64 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.59 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.5 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.41 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $253B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...